Atma Ram Bansal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Atma Ram Bansal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chaturbhuj Rathore
Department of Neurology Smt. B. K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth‐Deemed to be University Vadodara Gujarat India
2 shared publications - Kurupath Radhakrishnan
Comprehensive Epilepsy Care Center, KIMS HEALTH, Trivandrum, Kerala, India
2 shared publications - Neeraj Baheti
Department of Neurology G. M. Taori Central India Institute of Medical Sciences Nagpur Maharashtra India
2 shared publications - Annamma George
Speech Therapy Clinic Trivandrum Kerala India
1 shared publication - Aparna Sahu
Department of Neurology King Edward Memorial Hospital Mumbai Maharashtra India
1 shared publication - Avinash Kumar Seth
Department of Pharmacy Smt. B. K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth‐Deemed to be University Vadodara Gujarat India
1 shared publication
Latest Publications
Treatment gap in epilepsy is predicted more by patient perceptions than disease burden: Population‐based study from rural India
Objective: To identify predictors of primary and secondary epilepsy treatment gap (TGap) in a rural Indian community. Methods: We conducted a community‐based door‐to‐door survey of 130 509 individuals in 96 villages in rural Gujarat, India. Active epilepsy was diagnosed by neurologists using standard definitions and reasons for TGap were recorded. Primary TGap was defined as never receiving anti‐seizure medication (ASM) and secondary TGap as discontinuation of ASM after initiation. Clinical characteristics, healthcare utilization, patient perceptions, and quality of life‐31 (QOLIE‐31) were assessed. Multivariable logistic regression was performed to identify factors associated with TGap. Through a pragmatic intervention, we provided free ASM to untreated patients to evaluate long‐term treatment retention. Results: We identified 393 people with active epilepsy (prevalence 3.01 per 1000; 95% confidence interval [CI]: 2.72–3.32). Of 371 patients with treatment data, 247 (66.6%) had TGap, 127 (34.2%) primary and 120 (32.3%) secondary. Primary TGap was mainly attributed to lack of awareness and low perceived need for treatment (56%), whereas perceived cure was the leading reason for secondary TGap (35%). Financial and access barriers accounted for only 19% of reported reasons. Younger age, shorter epilepsy duration, higher seizure frequency, and lack of neurologist consultation were associated with TGap on univariable analysis. After adjustment, perception‐related variables, namely unawareness regarding ASM side‐effects, healthcare disengagement, faith‐healing beliefs, and preference for non‐specialist care, were found to be independent predictors of primary TGap. Patients with primary TGap had the poorest quality of life. Among 94 untreated patients offered free ASMs, only 32 (34.0%) remained in care at 3 months and 17 (18.1%) at 1 year. Significance: Primary and secondary TGap represent distinct entities and need different solutions. Rather than seizure disability or quality of life, patient perceptions and healthcare beliefs best predict treatment initiation. Improving ASM access alone is unlikely to substantially reduce the TGap.
Treatment gap in epilepsy is predicted more by patient perceptions than disease burden: Population‐based study from rural India
Objective: To identify predictors of primary and secondary epilepsy treatment gap (TGap) in a rural Indian community. Methods: We conducted a community‐based door‐to‐door survey of 130 509 individuals in 96 villages in rural Gujarat, India. Active epilepsy was diagnosed by neurologists using standard definitions and reasons for TGap were recorded. Primary TGap was defined as never receiving anti‐seizure medication (ASM) and secondary TGap as discontinuation of ASM after initiation. Clinical characteristics, healthcare utilization, patient perceptions, and quality of life‐31 (QOLIE‐31) were assessed. Multivariable logistic regression was performed to identify factors associated with TGap. Through a pragmatic intervention, we provided free ASM to untreated patients to evaluate long‐term treatment retention. Results: We identified 393 people with active epilepsy (prevalence 3.01 per 1000; 95% confidence interval [CI]: 2.72–3.32). Of 371 patients with treatment data, 247 (66.6%) had TGap, 127 (34.2%) primary and 120 (32.3%) secondary. Primary TGap was mainly attributed to lack of awareness and low perceived need for treatment (56%), whereas perceived cure was the leading reason for secondary TGap (35%). Financial and access barriers accounted for only 19% of reported reasons. Younger age, shorter epilepsy duration, higher seizure frequency, and lack of neurologist consultation were associated with TGap on univariable analysis. After adjustment, perception‐related variables, namely unawareness regarding ASM side‐effects, healthcare disengagement, faith‐healing beliefs, and preference for non‐specialist care, were found to be independent predictors of primary TGap. Patients with primary TGap had the poorest quality of life. Among 94 untreated patients offered free ASMs, only 32 (34.0%) remained in care at 3 months and 17 (18.1%) at 1 year. Significance: Primary and secondary TGap represent distinct entities and need different solutions. Rather than seizure disability or quality of life, patient perceptions and healthcare beliefs best predict treatment initiation. Improving ASM access alone is unlikely to substantially reduce the TGap.
- Open Access
- 16 July 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (5) , 1670-1684
A survey of the prevalence and patterns of neuropsychological assessment practices across epilepsy surgery centers in India: Toward establishing a national guideline
Neuropsychology plays an important role in optimizing epilepsy management, but there are no practice guidelines for low‐ and middle‐income countries with emerging services. The National Epilepsy Surgery Support Activity Network (NESSAN), a national working group that supports and optimizes epilepsy surgery programs in India, explored the present status of pre‐ and post epilepsy surgery neuropsychological assessment practices across India as an initial step in developing national evidence‐based test guidelines. An online survey was conducted using two questionnaires, one for neurologists and the second for neuropsychologists and speech–language pathologists working in epilepsy surgery centers. The questions to neurologists covered the setting, description, and nature of the neuropsychology services provided for adults and children as part of the epilepsy surgery program, and their perceptions about the importance and indications for neuropsychological assessment in epilepsy surgery. The questions to neuropsychologists inquired about their qualifications and training, pre‐ and postsurgical assessment procedures, and domain‐specific cognitive tests and scales for mood, quality of life, and language evaluations. Forty‐three centers responded, and neuropsychology services were available at three fourth of the centers, but a dedicated full‐time neuropsychologist was available in only 16% of centers. Ninety percent of the neurologists considered neuropsychological evaluation an indispensable part of presurgical evaluation. However, only a few of them believed that the results influenced their decision about the extent of resection and ruling against surgery. The survey found considerable heterogeneity in terms of qualifications and training of neuropsychologists, evaluation procedures, test protocols, and normative data that will need to be harmonized to ensure uniform practice across the country. We believe that the results from this survey provide a road map for implementing measures to minimize existing inadequacies and harmonize neuropsychology services in India and as well as in other countries with emerging neuropsychology services.Plain Language Summary: Neuropsychological assessment is an integral part of the pre‐ and post epilepsy surgery evaluations. In India, the National Epilepsy Surgery Support Activity Network (NESSAN), a body of multidisciplinary professionals, conducted a survey to examine existing neuropsychology practices. The responses from 43 centers across the country revealed considerable heterogeneity in tests and few trained and qualified neuropsychologists. In low‐ and middle‐income countries (LMIC) with emerging neuropsychology services, there is a need to have uniform test protocols, specialized training, and guidelines for optimizing neuropsychology services across all the epilepsy surgery centers.
- 16 July 2024
- Published by Wiley in Epilepsia Open
- Vol. 9 (5) , 1670-1684
Open AccessA survey of the prevalence and patterns of neuropsychological assessment practices across epilepsy surgery centers in India: Toward establishing a national guideline
Neuropsychology plays an important role in optimizing epilepsy management, but there are no practice guidelines for low‐ and middle‐income countries with emerging services. The National Epilepsy Surgery Support Activity Network (NESSAN), a national working group that supports and optimizes epilepsy surgery programs in India, explored the present status of pre‐ and post epilepsy surgery neuropsychological assessment practices across India as an initial step in developing national evidence‐based test guidelines. An online survey was conducted using two questionnaires, one for neurologists and the second for neuropsychologists and speech–language pathologists working in epilepsy surgery centers. The questions to neurologists covered the setting, description, and nature of the neuropsychology services provided for adults and children as part of the epilepsy surgery program, and their perceptions about the importance and indications for neuropsychological assessment in epilepsy surgery. The questions to neuropsychologists inquired about their qualifications and training, pre‐ and postsurgical assessment procedures, and domain‐specific cognitive tests and scales for mood, quality of life, and language evaluations. Forty‐three centers responded, and neuropsychology services were available at three fourth of the centers, but a dedicated full‐time neuropsychologist was available in only 16% of centers. Ninety percent of the neurologists considered neuropsychological evaluation an indispensable part of presurgical evaluation. However, only a few of them believed that the results influenced their decision about the extent of resection and ruling against surgery. The survey found considerable heterogeneity in terms of qualifications and training of neuropsychologists, evaluation procedures, test protocols, and normative data that will need to be harmonized to ensure uniform practice across the country. We believe that the results from this survey provide a road map for implementing measures to minimize existing inadequacies and harmonize neuropsychology services in India and as well as in other countries with emerging neuropsychology services.Plain Language Summary: Neuropsychological assessment is an integral part of the pre‐ and post epilepsy surgery evaluations. In India, the National Epilepsy Surgery Support Activity Network (NESSAN), a body of multidisciplinary professionals, conducted a survey to examine existing neuropsychology practices. The responses from 43 centers across the country revealed considerable heterogeneity in tests and few trained and qualified neuropsychologists. In low‐ and middle‐income countries (LMIC) with emerging neuropsychology services, there is a need to have uniform test protocols, specialized training, and guidelines for optimizing neuropsychology services across all the epilepsy surgery centers.
- 1 January 2010
- Published by Springer Nature
- p. 1109-1113
Primary Reading Epilepsy